Answers Available to the CTE Crisis in Professional Football and Beyond
Memphis, TN (PRWEB) March 28, 2016 -- As professional football and others wrestle with how to properly assess and manage individuals facing Chronic Traumatic Encephalopathy (CTE) and other head trauma concerns, a Memphis-based company has brought over 25 years of experience to significantly solve the problem.
Dr. Divyen Patel, founder and President of Genome Explorations has done extensive research in the genetic response to head trauma. As a result he has developed the most advanced genetic micro-array tools that serve as companion diagnostics to diagnose and treat patients. “There is no question these tools can be used by the NFL, by the military, police, and other venues,” said Dr. Patel. He added, “We have found the means by which we can detect the smallest mutation that brings the implication of head trauma to light well in advance of current techniques.” In summary, Genome Explorations has moved medical information from mere pathology to the molecular and genetic level. The tools have also proven useful for PTSD and are being reviewed by the National Guard.
The genetic panels developed by Dr. Patel and his team are transformational. “We have gone from caterpillar to butterfly,” said Steve Coplon, an executive, with Genome Explorations. He added, “The tests use all 3.2 billion genetic data points to identify mutations and aberrations. This is a great leap forward for those suffering from CTE, PTSD, and other traumas.”
Dr. Patel began his genomic research at St. Jude’s Children’s Research Hospital fighting children’s cancers and blood diseases. He has authored over 150 papers. His expertise has been used by over 500 academic institutions from all six continents. In addition, he was a contributor to the human genome mapping project. The panels have been clinically validated through the most rigorous review and accreditation.
“The public nature of the situation involving professional football calls for accelerating a resolution using the best technologies of the 21st century. Genome Explorations stands ready to bring our resources to the table,”
said Dr. Patel.
For Further Information Contact Steve Coplon @ 901-351-7733
Steve Coplon, Genome Explorations, +1 9013517733, [email protected]
Share this article